|
PRDM10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.455800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.741400E-01 |
| Normal-vs-Stage2 |
2.664000E-01 |
| Normal-vs-Stage3 |
9.592100E-04 |
| Normal-vs-Stage4 |
9.389900E-04 |
| Stage1-vs-Stage2 |
7.463000E-01 |
| Stage1-vs-Stage3 |
3.337200E-03 |
| Stage1-vs-Stage4 |
5.322300E-03 |
| Stage2-vs-Stage3 |
8.390400E-02 |
| Stage2-vs-Stage4 |
7.184200E-02 |
| Stage3-vs-Stage4 |
8.324000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.368400E-02 |
| Normal-vs-AfricanAmerican |
1.795810E-02 |
| Normal-vs-Asian |
1.820410E-01 |
| Caucasian-vs-AfricanAmerican |
4.392800E-01 |
| Caucasian-vs-Asian |
3.319800E-02 |
| AfricanAmerican-vs-Asian |
1.855570E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.801500E-03 |
| Normal-vs-Female |
2.832200E-01 |
| Male-vs-Female |
1.954350E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.996840E-01 |
| Normal-vs-Age(41-60Yrs) |
3.916400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.576900E-04 |
| Normal-vs-Age(81-100Yrs) |
2.081700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.362600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.063400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.204200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.587600E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.906300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.550400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.305700E-02 |
| Normal-vs-Grade 2 |
3.497000E-01 |
| Normal-vs-Grade 3 |
2.184900E-03 |
| Normal-vs-Grade 4 |
8.44600000000639E-05 |
| Grade 1-vs-Grade 2 |
2.615800E-02 |
| Grade 1-vs-Grade 3 |
3.388300E-04 |
| Grade 1-vs-Grade 4 |
8.00720000000421E-05 |
| Grade 2-vs-Grade 3 |
7.519600E-03 |
| Grade 2-vs-Grade 4 |
4.211900E-04 |
| Grade 3-vs-Grade 4 |
5.279600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.723200E-01 |
| Normal-vs-ccB subtype |
3.042900E-03 |
| ccA subtype-vs-ccB subtype |
2.572400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.876400E-02 |
| Normal-vs-N1 |
2.530000E-02 |
| N0-vs-N1 |
1.673650E-01 |
|
|
